Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

News

First in our series of pediatric CML case reviews: CML with priapism and loss of vision

Screenshot Pediatric CML case reportAugust  2024 - We are delighted to share the first case review in a new series dedicated to the treatment of pediatric CML (pCML) in low and middle-income countries (LMICs). This series aims to provide a comprehensive discussion of challenging pCML cases from various perspectives to enhance knowledge and improve patient outcomes.

The inaugural case in this series has been published by Roy Moulik N et al. in the July edition of Case Reports on Oncology Medicine as an open access publication. This landmark case discusses a 14-year-old boy from India diagnosed with CML complicated by priapism and loss of vision. The case was initially presented during our 2023 Regional Discussion Groups in South Asia, where it sparked insightful discussions on best practices in resource-limited settings.

Ride for a Cure: An Incredible Journey and Fundraising Effort

Ride for a Cure 2024PHOTO 2024 08 02 17 56 43

Ride for a Cure 2024 has concluded, marking an inspiring and challenging journey through the French Alps. Six dedicated cyclists from Incyte embarked on this 710km route, facing significant climbs and enduring the summer heat, all while raising crucial funds for the iCMLf. And, thanks to your support, the team reached their fundraising goal, raising over $10,000!

CML SUN - a global patient and physician survey by Novartis that explored the unmet needs of people living with CML

CML SUN Data InfographicAn editorial by Lisa Machado from the Canadian CML Network

It’s time to stop equating survival with quality of life
Feeling so fatigued that you can’t work, maintain a social life or do the things that bring you joy is not living

If you are someone who has the good fortune at this moment in time to not be living with an illness, or caring for someone who is, lean in: survival and quality of life are not the same things.

Certainly, faced with a choice between dying or living, most of us would gratefully choose the latter without taking a breath. In fact, that feeling of fear and the desperation to live — also felt by those who love us — is often overwhelming, crowding out any contemplation of what the living that we are holding out for will look like.

See you at the 2024 ESH-iCMLf John Goldman Conference on CML: Reserve your place at the John Goldman Conference on CML

Group picture KopieJuly 2024 - This year, we continue our tradition with the John Goldman Fun Run on Sunday morning before the start of the conference. Organized by the iCMLf, this annual charity run supports young scientists and physicians from low- and middle-income countries.
Secure your place now and be part of a great team of runners!

See you at the 2024 ESH-iCMLf John Goldman Conference on CML: Submit your abstract

CML2024 promo slide latebreaking abstractsJuly 2024 - As the ESH-iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy approaches, we are excited to invite you to join us in Prague from September 27-19, 2024. This prestigious conference remains a highlight in the CML community's calendar, featuring a comprehensive scientific program dedicated to the latest advancements in CML biology and therapy.

You still have more than two weeks to submit your abstract for the meeting.
The deadline for late-breaking abstracts for oral and poster presentations is July 31st, 2024.

See you at the iCMLf CML Highlights of EHA on July 3rd

Collage Hochhaus CrossJune 2024 - If you were unable to attend the EHA2024 Hybrid Meeting or wish to review the highlights afterward, we’ve got you covered!

Join our webinar ‘CML Highlights of EHA 2024’ on Wednesday, July 3rd at 1pm Central European Summer Time (CEST) on Zoom, part of our ongoing iCMLf Conversations series.

CML Highlights of EHA 2024 – Clinical and Biological Overview

Join our two experts as they discuss key aspects of the CML presentations:

  • Clinical overview: Professor Andreas Hochhaus
    Director of the Department of Hematology and Medical Oncology
    Jena University Hospital (Germany)

  • Biological overview: Professor Nick Cross
    Professor of Human Genetics at the University of Southampton
    Southampton (UK)

Please note the changed time!
Date: Wednesday, July 3rd at 1pm Central European Summer Time(CEST)